SCTL Key Statistics, Chart & Performance
The current stock price of SCTL is 1.1 USD. In the past month the price increased by 3.77%. In the past year, price increased by 2.8%.
SCTL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to SCTL. When comparing the yearly performance of all stocks, SCTL is one of the better performing stocks in the market, outperforming 98.08% of all stocks.
SCTL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SCTL. SCTL has a bad profitability rating. Also its financial health evaluation is rather negative.
SCTL Financial Highlights
Over the last trailing twelve months SCTL reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS increased by 40.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.64% | ||
| ROE | -22.61% | ||
| Debt/Equity | 0.01 |
SCTL Forecast & Estimates
10 analysts have analysed SCTL and the average price target is 1.12 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.1.
For the next year, analysts expect an EPS growth of 45.81% and a revenue growth 2.59% for SCTL
SCTL Ownership
SCTL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 31.53 | 965.082B | ||
| JNJ | JOHNSON & JOHNSON | 20.76 | 572.907B | ||
| MRK | MERCK & CO. INC. | 22.54 | 297.222B | ||
| PFE | PFIZER INC | 9.06 | 150.614B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 10.19 | 121.168B | ||
| ZTS | ZOETIS INC | 18.6 | 55.849B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.61 | 25.456B | ||
| VTRS | VIATRIS INC | 5.78 | 16.516B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.9 | 12.079B | ||
| AXSM | AXSOME THERAPEUTICS INC | 223.48 | 9.116B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SCTL
Company Profile
Societal CDMO, Inc. is a bi-coastal CDMO with capabilities spanning pre-investigational new drug (IND) development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a focus on small molecules. The company is headquartered in Exton, Pennsylvania and currently employs 275 full-time employees. The company went IPO on 2014-03-07. The firm is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. The company is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company’s products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms and facilities to handle highly potent compounds and controlled substances.
Company Info
SOCIETAL CDMO INC
1 E. Uwchlan Ave, Suite 112
Exton PENNSYLVANIA US
Employees: 275
Phone: 17705348239
SOCIETAL CDMO INC / SCTL FAQ
Can you describe the business of SOCIETAL CDMO INC?
Societal CDMO, Inc. is a bi-coastal CDMO with capabilities spanning pre-investigational new drug (IND) development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a focus on small molecules. The company is headquartered in Exton, Pennsylvania and currently employs 275 full-time employees. The company went IPO on 2014-03-07. The firm is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. The company is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company’s products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms and facilities to handle highly potent compounds and controlled substances.
What is the stock price of SOCIETAL CDMO INC today?
The current stock price of SCTL is 1.1 USD. The price increased by 0.92% in the last trading session.
Does SOCIETAL CDMO INC pay dividends?
SCTL does not pay a dividend.
How is the ChartMill rating for SOCIETAL CDMO INC?
SCTL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for SOCIETAL CDMO INC?
SOCIETAL CDMO INC (SCTL) currently has 275 employees.
Can you provide the market cap for SOCIETAL CDMO INC?
SOCIETAL CDMO INC (SCTL) has a market capitalization of 116.26M USD. This makes SCTL a Micro Cap stock.
Can you provide the ownership details for SCTL stock?
You can find the ownership structure of SOCIETAL CDMO INC (SCTL) on the Ownership tab.